📊 Q3 Earnings are here! Plan ahead with key data on upcoming stock reports - all in 1 placeSee list

Danaher Corporation (DHR)

Frankfurt
Currency in EUR
Disclaimer
245.35
-0.50(-0.20%)
Closed
DHR Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
244.35247.00
52 wk Range
172.30259.20
Bid/Ask
245.90 / 246.20
Prev. Close
245.85
Open
244.4
Day's Range
244.35-247
52 wk Range
172.3-259.2
Volume
711
Average Volume (3m)
404
1-Year Change
19.34%
Fair Value
Unlock
Fair Value Upside
Unlock
DHR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
290.00
Upside
+7.71%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 6 consecutive years
Show more

Danaher Corporation Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Compare DHR to Peers and Sector

Metrics to compare
DHR
Peers
Sector
Relationship
P/E Ratio
47.9x−1.4x−0.6x
PEG Ratio
−1.41−0.190.00
Price/Book
3.9x1.4x2.6x
Price / LTM Sales
8.2x4.3x3.3x
Upside (Analyst Target)
-47.4%44.5%
Fair Value Upside
Unlock30.2%6.0%Unlock

FAQ

What Is the Danaher (DHR) Stock Price Today?

The Danaher stock price today is 245.35.

What Stock Exchange Does Danaher Trade On?

Danaher is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for Danaher?

The stock symbol for Danaher is "DHR."

Does Danaher Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.40%.

What Is the Danaher Market Cap?

As of today, Danaher market cap is 178.01B.

What is Danaher Earnings Per Share?

The Danaher EPS is 5.68.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.